Literature DB >> 11926440

Qualitative findings on the experience of end-of-life care for hematological malignancies.

Pam McGrath1.   

Abstract

There is a loud silence in the literature on the issues related to palliative care for hematological malignancies. This article presents information that begins to address that silence. The limited research that is available indicates that, to date, patients with a hematological malignancy and their families received scant attention with regards to the provision of palliative care. The findings presented in this article demonstrates that families are enduring considerable hardship and are left with much emotional pain and many unresolved issues when such care is not offered. It is hoped that the findings presented in this article will be used for developing effective strategies to ensure that patients with hematological malignancies and their families, no less than any others, can be afforded the dignity and respect that the appropriate provision of palliative services ensures.

Entities:  

Mesh:

Year:  2002        PMID: 11926440     DOI: 10.1177/104990910201900208

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  10 in total

1.  Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists.

Authors:  D Hui; S Bansal; M Park; A Reddy; J Cortes; F Fossella; E Bruera
Journal:  Ann Oncol       Date:  2015-06-03       Impact factor: 32.976

2.  Management of Cancer Related Distress in Patients with a Hematological Malignancy.

Authors:  Tara A Albrecht; Margaret Rosenzweig
Journal:  J Hosp Palliat Nurs       Date:  2012-10-01       Impact factor: 1.918

3.  Cutting the research pie: a value-weighting approach to explore perceptions about psychosocial research priorities for adults with haematological cancers.

Authors:  C L Paul; R Sanson-Fisher; H E Douglas; T Clinton-McHarg; A Williamson; D Barker
Journal:  Eur J Cancer Care (Engl)       Date:  2011-05       Impact factor: 2.520

4.  Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.

Authors:  Dorothy McCaughan; Eve Roman; Alexandra G Smith; Anne C Garry; Miriam J Johnson; Russell D Patmore; Martin R Howard; Debra A Howell
Journal:  BMC Palliat Care       Date:  2018-02-21       Impact factor: 3.234

5.  Determinants of hospital death in haematological cancers: findings from a qualitative study.

Authors:  Dorothy McCaughan; Eve Roman; Alexandra G Smith; Anne Garry; Miriam Johnson; Russell Patmore; Martin Howard; Debra A Howell
Journal:  BMJ Support Palliat Care       Date:  2017-06-29       Impact factor: 3.568

6.  Living with relapsed myeloma: Symptoms and self-care strategies.

Authors:  Orlaith Cormican; Maura Dowling
Journal:  J Clin Nurs       Date:  2018-03-15       Impact factor: 3.036

7.  Use and timing of referral to specialized palliative care services for people with cancer: A mortality follow-back study among treating physicians in Belgium.

Authors:  Gaëlle Vanbutsele; Luc Deliens; Veronique Cocquyt; Joachim Cohen; Koen Pardon; Kenneth Chambaere
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

8.  Nursing in patients with hematological malignancies.

Authors:  Hana Geres; Rouslan Kotchetkov
Journal:  Int J Hematol Oncol       Date:  2020-05-04

9.  Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision-making.

Authors:  Yvan Beaussant; Florence Mathieu-Nicot; Lionel Pazart; Christophe Tournigand; Serge Daneault; Elodie Cretin; Aurélie Godard-Marceau; Aline Chassagne; Hélène Trimaille; Carole Bouleuc; Patrice Cuynet; Eric Deconinck; Régis Aubry
Journal:  BMC Palliat Care       Date:  2015-11-16       Impact factor: 3.234

10.  Preferred and actual place of death in haematological malignancy.

Authors:  D A Howell; H I Wang; E Roman; A G Smith; R Patmore; M J Johnson; A Garry; M Howard
Journal:  BMJ Support Palliat Care       Date:  2015-07-08       Impact factor: 3.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.